An indicator of antioxidant stress ability to evaluate neurofunctional changes in patients with acute ischemic stroke: preliminary findings
- PMID: 40610900
- PMCID: PMC12224356
- DOI: 10.1186/s12883-025-04295-1
An indicator of antioxidant stress ability to evaluate neurofunctional changes in patients with acute ischemic stroke: preliminary findings
Abstract
Background: Acute ischemic stroke (AIS) ranks among the most prevalent cerebrovascular conditions. The clinical interest lies in utilizing oxidative stress (OS) markers and antioxidant system indicators for diagnosing and predicting stroke development. Our objective was to identify a precise marker of antioxidant stress ability to assess neurofunctional alterations in AIS patients.
Methods: A total of 66 AIS patients, 33 of whom also had type 2 diabetes mellitus (T2DM), were selected for our study, and 30 patients without AIS and diabetes were used as controls. The total plasma homocysteine (Hcy) concentrations were determined via an enzymatic cycling assay. The reduced Hcy to oxidised Hcy concentration ratio (Hcy/HHcy) was determined using hollow fibre centrifugal ultrafiltration (HFCF-UF) technique we previously established.
Results: The Hcy/HHcy was significantly lower in AIS patients with T2DM compared with both controls (P = 0.0262) and AIS patients without T2DM (P = 0.0468). A positive correlation was found between total Hcy concentration and the National Institutes of Health Stroke Scale (NIHSS) score (P = 0.002, r = 0.561), while no correlation was observed in AIS patients without T2DM (P = 0.850, r=-0.034). In AIS patients, the Hcy/HHcy showed a positive correlation with the NIHSS score in those with T2DM (P = 0.037, r = 0.365) and a negative correlation in those without T2DM (P = 0.003, r=-0.497). In AIS patients with T2DM, the receiver operating characteristic's area under the curve (ROC-AUC) value for total Hcy concentration was 0.796, compared to 0.600 in those without T2DM. Furthermore, the ROC-AUC values of the Hcy/HHcy were 0.719 and 0.735 in AIS patients with and without T2DM, respectively.
Conclusion: Hcy/HHcy is anticipated to serve as a precise indicator for assessing antioxidant stress ability and evaluating neurofunctional alterations in AIS patients.
Keywords: Acute ischemic stroke; Antioxidant stress ability; Homocysteine; Homocystine; Neurofunctional changes.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study complies with the Declaration of Helsinki. The Ethics Committee of Hebei Medical University approved the study protocol (No.2021026), and informed consent was obtained from all participants. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.
Figures







Similar articles
-
Assessment of redox balance parameters among patients with acute ischaemic stroke.Neurol Neurochir Pol. 2025;59(3):272-282. doi: 10.5603/pjnns.104354. Epub 2025 May 30. Neurol Neurochir Pol. 2025. PMID: 40444669
-
Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale.Lipids Health Dis. 2025 Jul 2;24(1):228. doi: 10.1186/s12944-025-02650-2. Lipids Health Dis. 2025. PMID: 40604981 Free PMC article.
-
Clinical value of serum uric acid and homocysteine levels in predicting the occurrence of atrial fibrillation in patients with type 2 diabetes mellitus.Biomed Eng Online. 2025 Jul 9;24(1):86. doi: 10.1186/s12938-025-01418-0. Biomed Eng Online. 2025. PMID: 40634998 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi: 10.1002/14651858.CD003054.pub4. Cochrane Database Syst Rev. 2017. PMID: 29205264 Free PMC article.
References
-
- Towfighi A, Saver JL. Stroke declines from third to fourth leading cause of death in the united states: historical perspective and challenges ahead. Stroke. 2011;42(8):2351–5. - PubMed
-
- Donnan GA, Fisher M, Macleod M, et al. Stroke Lancet. 2008;371(9624):1612–23. - PubMed
-
- Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2006;2(7):182–7. - PubMed
-
- Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84. - PubMed
-
- Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009;4(6):461–70. - PubMed
MeSH terms
Substances
Grants and funding
- H2024206081/Natural Science Foundation of Hebei Province
- H2024206027/Natural Science Foundation of Hebei Province
- H2021206299/Natural Science Foundation of Hebei Province
- GZ2024040/The Tracking Project of Medical Applicable Technology in Hebei Province in 2024
- 2022/14th Five-Year Clinical Medicine Innovation Research Team
LinkOut - more resources
Full Text Sources
Medical